C9orf72 and autoimmune polyendocrinopathy: In conclusion, we did not find any evidence to support that intermediate repeat expansions in C9orf72 are a genetic risk factor for PSP, CBS, or APS, or that C9orf72 repeat size has a modifying effect on age at onset, disease severity at baseline assessment, or survival in this cohort.